An observational study in Stroke, sponsored by Chinese University of Hong Kong. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-01-14.
Sponsored by Chinese University of Hong Kong · Observational
The investigators retrospectively reviewed all patients with neurosurgical operations for hemorrhagic stroke (intracerebral hemorrhage) between 1999 and 2008. Research assistant then telephoned the survivors for neurological and cognitive status.
Death at one year for intracerebral hemorrhage varies by location, with 42% for cerebellar in one series. Of patients who had intracerebral hemorrhage in the United States during 2002, only 20% are expected to be functionally independently at 6 months. Although case series established the value of selected timely hematoma evacuation, long term clinical outcome, especially on cognition, is not well described in the literature. With these in mind, we carried out this study.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 191 is above the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Spontaneous intracerebral hemorrhage with neurosurgical operations
Exclusion Criteria:
Modified Rankin Scale
Time frame: Cross-sectional at 2-12 years after ictus
Barthel Index
Basic Activity of Daily Living
Time frame: Cross-sectional at 2-12 years post-ictus
Telephone Interview of Cognitive Status
Time frame: Cross-sectional at 2-12 years post-ictus
This study is completed, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chinese University of Hong Kong